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Abstract
Background: Francisella tularensis is a highly virulent human pathogen. The most virulent strains belong to subspecies
tularensis and these strains cause a sometimes fatal disease. Despite an intense recent research effort, there is very limited
information available that explains the unique features of subspecies tularensis strains that distinguish them from other F.
tularensis strains and that explain their high virulence. Here we report the use of targeted mutagenesis to investigate the
roles of various genes or pathways for the virulence of strain SCHU S4, the type strain of subspecies tularensis.
Methodology/Principal Findings: The virulence of SCHU S4 mutants was assessed by following the outcome of infection
after intradermal administration of graded doses of bacteria. By this route, the LD50 of the SCHU S4 strain is one CFU. The
virulence of 20 in-frame deletion mutants and 37 transposon mutants was assessed. A majority of the mutants did not show
increased prolonged time to death, among them notably DpyrB and DrecA. Of the remaining, mutations in six unique
targets, tolC, rep, FTT0609, FTT1149c, ahpC, and hfq resulted in significantly prolonged time to death and mutations in nine
targets, rplA, wbtI, iglB, iglD, purL, purF, ggt, kdtA, and glpX, led to marked attenuation with an LD50 of .10
3 CFU. In fact, the
latter seven mutants showed very marked attenuation with an LD50 of $10
7 CFU.
Conclusions/Significance: The results demonstrate that the characterization of targeted mutants yielded important
information about essential virulence determinants that will help to identify the so far little understood extreme virulence of
F. tularensis subspecies tularensis.
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Introduction
Francisella tularensis is a facultative intracellular bacterium that is
highly virulent and highly contagious and one of the agents given
highest priority in the offensive biological weapons programs of the
US and Soviet Union during the Cold War [1]. Besides this
notoriety, it is most often encountered in nature as the etiological
agent of a potentially lethal disease, tularemia [2]. It occurs in a
wide variety of mammals, most frequently in small rodents, hares,
and rabbits. In humans, it is a rare disease in most countries but
epidemic outbreaks occur in certain areas of the world, e.g.,i n
Finland, Russia, and Sweden [3]. Often it is spread via vectors
such as ticks, biting flies or mosquitoes. Besides vector bites, it is
capable of infecting the hosts via a variety of other routes such as
inhalation, direct contact, ingestion of contaminated food or
water. The most serious form of tularemia is contracted via
inhalation [4]. Regardless of how the infection was established, the
target organs are draining lymph nodes, liver, spleen, and lung.
The pathology in these organs appears to be similar in rodents and
humans and therefore the mouse model has become a commonly
used experimental model [5].
In 1959, it was recognized that F. tularensis isolates show distinct
virulence differences for many host species [6]. In particular, some
strains unique to North America demonstrated very high virulence
for most animal species tested and they gave rise to very serious
forms of clinical disease with very high mortality [7]. This
subspecies is designated F. tularensis subspecies tularensis, or type A.
In humans and experimental animals, doses of 10 bacteria or less
can cause severe infection and the mortality of human respiratory
tularemia caused by such strains may be 30% or higher without
proper antibiotic treatment [8]. Epidemiological information
gathered recently indicated that there are two variants of
subspecies tularensis, AI and AII, and that the former is responsible
for the most serious types of tularemia [9]. The less virulent
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5463subspecies of F. tularensis encountered in Europe, Asia, as well as
North America is named holarctica, also type B. The subspecies is
often associated with semi-aquatic rodents [7]. In Europe,
tularemia is most frequently observed in hares and rodents.
Due to re-emergent concerns about its potential use as a
weapon of mass destruction by terrorists, the development of
Francisella vaccines has been given high priority [10]. During the
1940’s and 50’s, extensive efforts were undertaken in the Soviet
Union to develop a live vaccine and several attenuated vaccine
strains were generated by repeated passages of a subspecies
holarctica strain on media containing serum which led to an
irreversible attenuation. One of these was transferred to the USA,
and was used to derive the current live vaccine strain (LVS) [10].
In humans, LVS administered by scarification confers excellent
protection against systemic challenge with high doses of subspecies
tularensis and against lower doses of inhaled bacteria [10].
Therefore, development of an improved vaccine against aerosol
exposure has become an important goal. It has been postulated
that protection against the highly virulent type A subspecies might
be optimal if the vaccine is based on a homologous strain
containing potentially protective antigens missing from subspecies
holarctica [10]. Until a few years ago, a targeted mutagenesis
strategy for F. tularensis was hampered by limitations in the
available genetic tools and selection markers. However, several
examples of targeted mutations in the prototypic SCHU S4 strain
have recently been reported. The targets include the O-antigen
locus wbtDEF, purMCD, katG, FTT0918, iglC, FTT1103, and dsbB
[11,12,13,14,15,16]. All of these mutants, with the exception of
katG, showed variable degrees of attenuation, but most of them e.g.,
wbtDEF, iglC, purMCD, and dsbB appeared to confer little or no
protection against a challenge with wild-type SCHU S4
[11,12,14,15]. Immunization with FTT0918 afforded solid
protection against intradermal challenge and a partial protection
against a low-dose aerosol challenge with the parental strain [14].
However, DFTT0918 showed an LD50 of 10
4–10
5 CFU which is
less than LVS which has an LD50 of .10
6 CFU. The only
example so far of a markedly attenuated strain that confers
protection appears to be DFTT1103 [16]. Thus, there is a shortage
of attenuating targets that still preserve the immunogenicity of the
corresponding deletion mutants. One drawback in the work to
rationally identify such targets has been our rudimentary
knowledge regarding the virulence mechanisms of F. tularensis.I t
is phylogenetically distant from all other human pathogens, and
consequently a high proportion of its genes are unannotated and
predictions of its virulence pathways in silico are uncertain [17].
Moreover, many mechanisms, such as type III and type IV
secretion systems, essential for the virulence of many other
intracellular bacteria are missing in F. tularensis. Much research has
been focused on the role of a large pathogenicity island of some 20
genes that is present in two copies in all F. tularensis genomes except
that of F. novicida [18]. Among these, in particular, the intracellular
growth locus (igl) operon has been studied intensively since it
appears to be essential for the intracellular replication of the
bacterium [19,20,21,22,23,24,25,26]. Also, the pil system has been
the focus of much research [27,28,29,30] and also the F. tularensis
mechanisms for acquisition of iron, leading to the identification of
the fsl operon [31,32]. Despite the recently rapid progress of F.
tularensis research, much remains to be understood about the
pathogenicity of this enigmatic bacterium. One way to address this
will be to characterize the phenotypes of targeted mutants since it
will yield important information regarding pathways essential and
non-essential for the virulence of F. tularensis. We have investigated
the contribution to virulence of various F. tularensis genes or
pathways by creating transposon or deletion mutants and testing
their virulence in the well-established mouse model. Here we
describe the findings related to the generation of 20 deletion and
37 transposon mutants.
Results and Discussion
Throughout the manuscript, the term virulence factor will be
used in accordance with the definition proposed by Wood et al; ‘‘A
component of a pathogen that when deleted specifically impairs
virulence but not viability’’ [33]. We observed impaired growth of
the purL and purF mutants in Chamberlain’s broth but not on agar
plates (Table 1). The kdtA mutant showed delayed multiplication at
6 h but reached a high density after 24 h whereas all other
mutants described herein showed a growth pattern indistinguish-
able from SCHU S4 regardless of medium used (Table 1).
Therefore, we find the use of the term virulence factor to be
appropriate when the corresponding mutants showed an attenu-
ated phenotype, with the exception of the three aforementioned
mutants.
Using a standard procedure for transposon insertion mutagen-
esis of SCHU S4 [34], a total of 743 mutants were generated by
screening on plates containing kanamycin. Of these, 159 were
characterized by sequencing of the targeted gene. Some of the
insertion mutants were analyzed for virulence in the mouse model
based on intradermal (ID) administration of graded doses of
bacteria. In this model, even the lowest inocula of ,10 CFU of
SCHU S4 invariably resulted in a lethal infection [35]. Since one
aim of the work was to identify attenuating targets that can serve
as the basis for generation of live vaccine candidates, the goal was
to avoid mutations that conferred marginal attenuation and
therefore the first screen was performed based on the administra-
tion of a dose of 1,000 CFU. In total, 37 transposon mutant strains
were screened. Only strains with insertions in annotated genes
with defined biological roles were included and these are listed in
Table 2. The screen identified a number of attenuating targets,
most markedly the following genes; FTT0141 (rplA), FTT1455c
Table 1.
Mutant strain Bacterial growth
a
6h 2 4h
SCHU S4 1.75
b $2.00
Tn-purF
c 0.29 0.29
Tn-purL 0.29 0.30
Tn-kdtA 1.74 $2.00
Tn-rplA 1.45 1.90
DiglB 1.70 $2.00
DiglD 1.75 $2.00
Dggt 1.78 $2.00
DkdtA 0.86 1.62
DwbtI 1.57 $2.00
DglpX 1.62 1.88
control 0 0
aAn overnight culture of the indicated strain was inoculated in Chamberlain’s
medium to an OD600 of 0.2. Data shown is from one representative experiment
out of three.
bThe optical density (OD600) at the indicated time point is shown.
cTn indicates that the strains are transposon mutants.
doi:10.1371/journal.pone.0005463.t001
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which all had an LD50$10
3 CFU.
In F. tularensis, rplA (FTT0141), encoding the 50S ribosomal
protein L1, and rplK, encoding the 50S protein L11, are predicted
to be transcribed by the same operon. Also in Corynebacterium
glutamicum, the rplK and rplA genes have been identified as co-
transcribed and required for the activation of the RelA protein
[36], the source of the initiator of the stringent response,
(p)ppGpp, an adaptation to amino acid starvation [37]. Even if
F. tularensis harbors both relA and spoT homologues, two enzymes
which appear to substitute for each other in many cases, it is
possible that expression of the rpl operon still is required in order to
activate the stringent response and, thus, the attenuation of the
rplA mutant may depend on an impaired adaptation to amino acid
starvation. The relevance of the findings regarding the kdtA, wbtI,
and pur mutants are discussed later.
Among the tested Tn mutants, a challenge of 10
3 CFU with
three additional strains, FTT1724c (tolC), FTT0609, FTT1087c
Table 2. Transposon mutant strains included in this study.
Designation
Gene
target
Degree of
attenuation (LD50)
Insertion
location
a Function References
rplA FTT0141 .10
3 CFU 19 50S ribosomal protein L1
purF FTT1721 .10
7 CFU 17 Amidophosphoribosyl-transferase [42,44]
purL FTT1720c .10
7 CFU 10 phosphoribosylformylglycinamide synthase [40,42,44]
kdtA FTT1561 .10
3 CFU 1 3-deoxy-D-manno-octulosonic-acid transferase
wbtI FTT1455 .10
3 CFU LPS O-antigen synthesis
tolC FTT1724c ,10
3 CFU* 39 outer membrane efflux protein
FTT0609 FTT0609 ,10
3 CFU* 69 Unannotated
rep FTT1087c ,10
3 CFU* 22 UvrD/REP superfamily I DNA and RNA helicases [41]
lon FTT0626 ,10
3 CFU 76 DNA-binding, ATP-dependent protease La [41,43]
tig FTT0623 ,10
3 CFU 69 trigger factor (TF) protein (peptidyl-prolyl cis/trans isomerase), chaperone [43]
ppdK FTT0250 ,10
3 CFU 45 phosphoenolpyruvate synthase/pyruvate phosphate dikinase
FTT0069 FTT0069c ,10
3 CFU 12 Unannotated
FTT1640c FTT1640c ,10
3 CFU 39 activator of osmoprotectant transporter ProP, fragment [44]
tet FTT0444 ,10
3 CFU 73 drug:H+ antiporter-1 (DHA1) family protein [43]
pilO FTT1158c ,10
3 CFU 46 Type IV pili glycosylation protein
htpX FTT0862c ,10
3 CFU 50 Zn-dependent protease with chaperone function
asd FTT0425c ,10
3 CFU 30 aspartate semialdehyde dehydrogenase
prfC FTT0118 ,10
3 CFU 37 peptide chain release factor 3 [44]
fslE FTT0026c ,10
3 CFU 28 siderophore uptake
trpB FTT1773c ,10
3 CFU 27 tryptophan synthase beta chain
hslU FTT0687c ,10
3 CFU 63 ATP-dependent protease HslVU, ATPase subunit
yjjK FTT1782c ,10
3 CFU 80 ABC transporter ATP-binding protein [43,44]
usp FTT0245 ,10
3 CFU 20 universal stress protein
omp26 FTT1542c ,10
3 CFU 36 protein of unknown function
elbB FTT0654 ,10
3 CFU 90 DJ-1/PfpI family protein [41,43]
ipdC FTT1744c ,10
3 CFU 8 indolepyruvate decarboxylase
FTT0156 FTT0156 ,10
3 CFU 25 Unannotated
rnhB FTT1278c ,10
3 CFU 81 ribonuclease HII
glpA FTT0132 ,10
3 CFU 27 glycerol-3-phosphate dehydrogenase
uvrA FTT1312c ,10
3 CFU 68 DNA excision repair enzyme, subunit A [43]
trpE FTT1802c ,10
3 CFU 35 anthranilate synthase component I [41]
tgt FTT1120c ,10
3 CFU 4 queuine tRNA-ribosyltransferase
FTT0891 FTT0891 ,10
3 CFU 73 Conserved hypothetical membrane protein [44]
cphA FTT1130c ,10
3 CFU 65 Cyanophycin synthetase [44]
aroC FTT0876c ,10
3 CFU 1 Chorismate synthase [41]
mutL FTT0486 ,10
3 CFU 96 DNA mismatch repair enzyme with ATPase activity
moxR FTT0290 ,10
3 CFU 37 MoxR-like ATPase
bipA FTT1179 ,10
3 CFU 66 GTP-binding translational elongation, factor Tu and G family protein [41,43]
*extended time to death, .7 days.
ain % of gene length from 59 end.
doi:10.1371/journal.pone.0005463.t002
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compared to 5 days for mice infected with SCHU S4 (Figure 1A).
The function of TolC of F. tularensis LVS has been investigated and
it was proposed to be involved in a multidrug resistance
machinery, however, it showed no defective replication in murine
bone marrow-derived macrophages but significant attenuation of
virulence in a mouse model [38]. It was hypothesized that it
functions as part of a type I secretion system. Our present findings
indicate that in SCHU S4, TolC makes a marginal contribution to
the virulence.
FTT0609 encodes a peptidase of the M24 family protein. The
homologues have not been described as virulence determinants
but a similar peptidase has been identified in Lactobacillus delbrueckii
and found to be a dipeptidase active on X-proline dipeptides [39].
FTT1087c (rep) encodes an ATP-dependent DNA helicase that
never has been described as a virulence factor.
It should be remarked that the interpretation of the results with
these mutants can be confounded by some inherent ambiguities of
the transposon insertion strategy. First, the insertions may lead to
polar effects if the targeted gene is located in the upstream part of
an operon. Thereby, the phenotype observed may depend on the
disrupted or impaired transcription of another gene of the operon.
Second, a lack of phenotype cannot unambiguously rule out an
important role of the target since the location of the insertion may
be downstream of a biologically active site. The exact locations of
the insertions are indicated in Table 2. Third, they might exhibit
more overt attenuation at lower challenge doses.
Notably, two out of the five mutants identified in our analysis as
markedly attenuated, rplA and kdtA, were not identified in any of
five studies intended as whole-genome screens of virulence factors
of F. tularensis [40,41,42,43,44]. Three of these studies were based
on F. novicida [40,41,44] and one on F. tularensis LVS [43] and
some of the differences may relate to the use of other model
organisms than SCHU S4. Also, administration routes may affect
the results, since two of the studies employed inhalation models
[41,43]. The only previous study using SCHU S4 assessed the
intracellular replication in a hepatic cell line but not growth in vivo
[42]. The targets included in the present study that had been
identified in any of the five previous studies as virulence factors are
listed Tables 2 and 3. Of the 30 transposon mutants that did not
show any degree of attenuation or extended time to death, 13 had
been identified in one or more of the aforementioned four studies
as virulence factors. The most likely reason that we did not identify
them is that the degree of attenuation in SCHU S4, if any, is less
than the 10
3 CFU used for challenge. Also, since eight were
identified in only the studies based on inhalation models, the route
of administration and the use of other model organisms may be
contributing factors.
All 20 mutants described henceforth were generated as in-frame
deletions of the target genes. All investigated mutants are listed in
Table 3. F. tularensis strains harbor a 31.2 kb locus, designated the
Francisella pathogenicity island (FPI), containing some 20 genes,
many of which appear to execute functions necessary for its
intracellular life cycle [18]. The bacterium initially resides in a
phagosome before it escapes into the cytoplasm via degradation of
the phagosomal membrane. This is followed by extensive
replication in the cytosol leading to apoptotic death of the
macrophage and bacterial egress [45]. Among the FPI, the genes
encoded by the igl locus have attracted most attention. It has been
suggested that iglA and iglB genes contribute to a type VI secretion
system although direct proof of a functional secretion system is
lacking [21]. Functions encoded by the operon appear to be
essential for the phagosomal escape and intracellular growth, since
disruptions or deletions of FPI encoded genes of the low virulent
strains F. tularensis LVS and F. novicida, such as iglA, iglB [21,46],
iglC [22,23,25,26], and iglD [19,47], all are predominantly
contained within the phagosome and unable to replicate
intracellularly. Therefore, the findings collectively suggest that
their functions are critical for the early stages of F. tularensis
intracellular trafficking. These defects lead to highly attenuated
phenotypes in vivo since the iglC mutants of LVS and SCHU S4 are
essentially avirulent in mice [14,22]. Moreover, we previously
observed that immunization with DiglC conferred only a marginal
degree of protection against a subsequent challenge with a strain of
subspecies tularensis and hypothesized that this is due to its limited
replication in vivo [14].
In agreement with our previously published results on DiglC
[14], we here observed that both the DiglB and DiglD mutants
showed marked attenuation (Table 3) but provided only marginal
protection against SCHU S4 challenge (data not shown). Similar
to our recent findings based on the same mutants in LVS [19,46],
the results suggest that expression of each of the IglB, IglC, and
IglD proteins is essential to the virulence of F. tularensis and the
absence of any one of them leads to very significant attenuation
even of the highly virulent strain SCHU S4.
Since information on 15 F. tularensis genomes is present in public
databases, there is ample amount of genetic information available
for comparative genomic studies. This has resulted in the
identification of a number of regions exclusively present in
genomes of subspecies tularensis strains. The first description of
such regions identified eight so called regions of difference (RD),
altogether comprising 21 open reading frames [48]. One of these
regions, RD5, contained two ORFs, FTT0522 - FTT0523, that
Figure 1. Survival of transposon and deletion mutants of SCHU S4. In A) BALB/c mice were challenged intradermally with 1000 CFU of SCHU
S4 (square), DFTT0609 (triangle), DtolC (circle), or Drep (diamond). In B) BALB/c mice (n=5/group) were challenged intradermally with 10 CFU of SCHU
S4 (square), DFTT1149 (diamond), DahpC (triangle), or Dhfq (circle).
doi:10.1371/journal.pone.0005463.g001
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present in Shewanella oneidensis and a type I restriction enzyme
from Bacteroides thetaiotamicron. A second region, RD8, contained an
11.2 kb region unique to subspecies tularensis strains, however, at
least two of the eight ORFs were predicted to be pseudogenes.
FTT1071 is among the intact RD8 genes and it shows similarity
to a gene encoding an antirestriction protein from Nitrosomonas
europaea. Moreover, the region designated RD2 contains oppD
(FTT0125) which is a unique gene in subspecies tularensis strains,
since a 960 bp internal deletion in subspecies holarctica strains has
resulted in a fused ORF with a disrupted oppD coding sequence
[48]. Mutants lacking the gene/genes of each of the three regions
were constructed but each of the mutants showed full virulence
in the mouse model, killing mice at an intradermal dose of 10
CFU with no extended time to death compared to SCHU S4
(Table 3). Therefore, our results did not in any way indicate that
these type A-unique genes contribute to the high virulence of the
subspecies.
An extensive comparative genomic analysis by Rohmer et al
identified 35 genes that displayed unique sequence variations
changing the protein content of the corresponding proteins in LVS
compared to other investigated F. tularensis strains [49]. Of these 35
genes, 15 were predicted to have lost the function of the encoded
proteins and seven of the latter were found to be under strong
selective pressure. Among the seven, FTT1149, an amino acid
transporter family protein, and FTL1521 (chiA), a chitinase family
18 protein were found. The latter protein was found to be over-
expressed by subspecies tularensis during in vivo growth, and
secreted in vitro by F. novicida by a type IV pilus secretion system
[28]. Secreted chitinases are essential for the establishment of the
arthropod infection by malaria parasites [50] and therefore their
presence in F. tularensis may be of biological relevance. However,
we could not detect any attenuation of the chiA mutant (Table 3).
Thus, this chitinase appears to play no role in the mouse model by
the intradermal route but since F. tularensis is an arthropod-borne
bacterium, it is possible that it plays a role in tularemia spread via
such vectors. The FTT1149 mutant demonstrated no increased
LD50 in as much as a dose of 10 CFU uniformly killed mice, but
the mean time to death was significantly prolonged (Figure 1B).
Thus, the predicted loss of function of this gene in LVS may make
a marginal contribution to its attenuation.
Mutations of pur genes often confer marked attenuations as
exemplified by purL mutants in Brucella abortus [51] and purE in B.
melitensis [52]. As aforementioned, when screening a library of
transposon mutants in the mouse model, we identified attenuated
mutants with an insertion in the purL as well as the purF genes.
Both genes function in the early stage of purine biosynthesis. Both
of these mutants were found to be considerably attenuated as mice
survived inocula of 10
7 CFU (Table 2). Mice that survived after
administration of 10
5 CFU were challenged intradermally with 10
Table 3. Deletion mutant strains included in this study.
Designation Gene target
Degree of
attenuation (LD50)
Deleted region
a [total
number of codons] Function References
DiglB DFTT1358,
DFTT1713
.10
7 CFU 61–354 [515] intracellular growth locus [43,44]
DiglD DFTT1356,
DFTT1711
.10
7 CFU 1–125+RBS [402] intracellular growth locus [41,44]
DRD5 DFTT0522-0523 ,10
1 CFU 30(FTT0522)–380 (FTT0523)
[326–409]
type I restriction-modification system
DRD8 DFTT1071 ,10
1 CFU 29–140 [169] anti restriction-modification system
DoppD DFTT0125 ,10
1 CFU 13–299 [323] peptide/opine/nickel uptake transporter,
PepT family proteins
DchiA DFTT0715 ,10
1 CFU 3–756 [761] chitinase, glycosyl hydrolase family 18
DFTT1149 DFTT1149 ,10
1 CFU* 16–482 [503] amino acid-polyamine-organocation
(APC) superfamily
DpyrB DFTT1665 ,10
1 CFU 2–297 [307] aspartate carbamoyltransferase [42,44]
DrecA DFTT1750 ,10
1 CFU 14–351 [360] recombinase A protein [41,43]
DmdaB DFTT0961 ,10
1 CFU 23–175 [197] recombinase A protein [41]
Dgpx DFTT0733 ,10
1 CFU 13–143 [157] glutathione peroxidase
DahpC DFTT0557 ,10
1 CFU* 3–160 [175] peroxiredoxin of the AhpC/TSA family
DsodC DFTT0879 ,10
1 CFU 23–178 [186] superoxide dismutase (Cu-Zn) precursor
DrimK DFTT0178 ,10
1 CFU 28–489 [490] glutathione synthase/ribosomal protein S6
modification enzyme
Dggt DFTT1181 .10
5 CFU 4–591 [602] gamma-glutamyltranspeptidase [42]
DkdtA DFTT1561 .10
7 CFU 53–351 [432] 3-deoxy-D-manno-octulosonic-acid transferase
DwbtI DFTT1455 .10
7 CFU 40–319 [361] sugar transamine/perosamine synthetase
Dhfq DFTT0630 ,10
1 CFU* 3–96 [110] host factor I for bacteriophage Q beta replication
DpckA DFTT0449 ,10
1 CFU 11–527 [531] phosphoenolpyruvate carboxykinase
DglpX DFTT1631 .10
7 CFU 19–312 [329] fructose 1,6-bisphosphatase II [41,43,44]
*extended time to death, .7 days.
alocalization of the deleted region with regard to the codon number of the encoding gene.
doi:10.1371/journal.pone.0005463.t003
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death compared to naı ¨ve mice.
The same two mutants, as well as additional pur mutants, were
identified in a screen performed by Qin et al when they searched
for transposon mutants that showed defective intracellular
replication [42]. Thus, an intact purine metabolic pathway
appears to be very important for the growth intracellularly and
in vivo of F. tularensis. This is not surprising since it appears to be the
case for many other pathogens [51,52,53,54]. Extensive work has
been carried out in F. tularensis characterizing a purMCD mutant of
SCHU S4 as well as of LVS [12]. Both showed marked
attenuation and protected against intradermal challenge with the
parental strain, but there was no protection against intranasal
challenge [12]. The effects of pur mutations have been assessed also
in subspecies novicida and it was found that immunization with a
purF mutant provided protection against a challenge with wild-type
novicida whereas purA, purCD, purL, and purM mutants were not
attenuated and did not protect mice against a homologous
challenge [40,55]. Neither a purF nor purA F. novicida mutant
afforded protection against a challenge with SCHU S4 [55]. Thus,
similar to our results, the findings indicate that the attenuation
conferred by defects in the many of the purine metabolism genes
does not yield mutants that are capable of inducing protective
immunity. One reason may be that marked attenuation leads to
shorter overall survival of the mutants and thereby limited
induction of protective T cells. The findings may be analogous
to those observed when infection is terminated by antibiotic
treatment. North et al reported that abridging a Listeria infection
with antibiotic treatment resulted in a quick loss of protective T
cells from the spleen and they concluded that the onset and
duration of decay of the protective response was determined by the
number of replicating bacteria in the tissues [56]. Thus, mutations,
such as those in igl, wbt and pur genes that significantly impair the
bacterial survival in vivo may lead to much less vigorous priming of
protective T cells.
Mutations in pyrimidine biosynthesis pathways have been
investigated in many bacterial species and generally they confer
attenuation. In fact, also in F. tularensis SCHU S4, the pyrimidine
pathway has been demonstrated to be important for intracellular
growth, since a pyrB transposon mutant of SCHU S4 showed
decreased growth rate in HepG2 cells [42]. It was also reported
that infected mice showed an extended time to death after
administration of low doses of the mutant although they all died
after administration of 200 CFU [42]. We observed no survivors
with an inoculum of 10 CFU of a pyrB deletion mutant indicating
that the attenuation was marginal at most (Table 3). This indicates
that in vivo the genes needed for the generation of pyrimidines, at
least pyrB, are not as essential as those needed for purine synthesis.
Central to the survival of pathogenic microorganisms is the
ability to withstand the stress conferred by reactive oxygen
metabolites since these are important defence mechanisms
expressed by infected mammals, in particular by the oxidative
burst of phagocytic cells. These defense mechanisms include
enzymes that detoxify reactive oxygen species, such as superoxide
dismutase (Sod), catalase (KatG), alkyl hydroperoxide reductase
(AhpC), glutathione peroxidase (GpX) and DNA repair systems
(Rec), which repair damage resulting from oxidative stress.
Additional protective mechanisms involve proteins that reduce
the quinone pool using NADPH as the reductant, e.g., MdaB.
Previously, we observed that a KatG mutant of LVS and SCHU
S4 showed significantly increased susceptibility to hydrogen
peroxide [13]. However, only the LVS mutant demonstrated
significant attenuation. In the present study we found that SCHU
S4 gpX, sodC, mdaB, and ahpC mutants demonstrated no increased
LD50 although ahpC showed a significant prolonged time to death
at a challenge dose of 10 CFU (Figure 1B). Collectively, our results
demonstrate that F. tularensis possesses a variety of means to
compensate for loss of major oxidative stress-combating factors
and that the important enzymes have overlapping functions. The
compensatory mechanisms are sufficient to allow replication so
that the specific mutants exhibit at most marginal attenuation in
vivo. However, considering the extended time to death, it is likely
that the ahpC mutant, like the previously described katG mutant
[13], has an impaired rate of replication in target organs indicating
an important function for AhpC. Notably, despite five conjuga-
tions, no mutants with combined deletions of ahpC and katG were
isolated. This may indicate that the combined mutations conferred
a compromised phenotype with low viability.
To assess the relative importance of DNA repair systems, recA
was deleted. The recA mutant did not demonstrate any significant
attenuation in the mouse model. The F. tularensis RecA has been
recombinantly expressed and shown to suppress the sensitivity of
the carrier to DNA-damaging agents in E. coli, thereby confirming
an important role of the enzyme [57]. Thus, it appears likely that
F. tularensis possesses additional DNA repair systems to compensate
for the absence of RecA. The findings are similar to those on recA
mutant of Mycobacterium bovis BCG [58]. It was found that the
mutant had intact virulence for mice and a normal dormancy
response, i.e., the entry into a non-replicative persistent phase as an
adaptation to a decrease in oxygen tension.
Hfq is a bacterial RNA chaperone involved in the posttran-
scriptional regulation of many stress-inducible genes via small
noncoding RNAs and found to be essential for expression of
virulence in several bacteria, e.g., uropathogenic E. coli and
Pseudomonas aeruginosa [59,60]. It also appears to play important
roles for resistance to reactive nitrogen and oxygen radicals [59].
In F. tularensis, a recent study found that an Hfq mutant of a
subspecies holarctica strain contributed to its stress tolerance and
was attenuated in a mouse model [61]. In the latter case, the
difference was found using a competition infection experiment
whereas the difference in average time to death was at most 2 days.
We observed that mice infected with 10 CFU of Dhfq lived
significantly longer than those infected with SCHU S4 although
the former mice all died within 8 days (Figure 1B). Thus, the role
of Hfq appears to be at most marginal for the virulence of SCHU
S4 but considering that the difference compared to the parental
strain was marginal also in subspecies holarctica, the contribution of
Hfq may not be distinct between subspecies tularensis and holarctica.
Gluconeogenesis in the absence of pyruvate requires the
functions of phosphoenolpyruvate carboxykinase (PEPCK), en-
coded by pckA, which catalyses the decarboxylation and phos-
phorylation of oxaloacetate to form phosphoenolpyruvate (PEP)
[62]. The enzyme can also perform the conversion of PEP to
oxaloacetate to maintain the TCA cycle. PEPCK is thought to be
of particular importance when organisms are exploiting fatty acids
as their major carbon source and it was found to be important in
mycobacteria since a pckA mutant of BCG was attenuated both
with regard to intramacrophage growth and in mice [63]. On the
other hand, it is dispensable in Salmonella enterica [64]. In the latter
species, even a ppsApckA double mutant showed only a marginal
degree of attenuation indicating that gluconeogenesis plays, at
most, a minor role for Salmonella virulence. The gene ppsA encodes
for phosphoenolpyruvate synthase, which produces PEP from
pyruvate. In Salmonella, the combined deletions completely block
gluconeogenesis above pyruvate [64]. We observed no attenuation
of the DpckA mutant (Table 3) but whether its role is in the
gluconeogenic pathway for carbohydrate formation, or in the
conversion of PEP to oxaloacetate to maintain the TCA cycle,
Virulence Genes of SCHU S4
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5463remains to be determined. However, we observed that a glpX
mutant demonstrated marked attenuation. Although the exact
function of the F. tularensis GlpX has to be determined
experimentally, in E. coli, the enzyme converts fructose-1,6-
bisphosphate to fructose-6-phosphate (Fbp) as part of the
gluconeogenesis but E. coli also possesses a second enzyme,
fructose-1,6-bisphosphatase (fbp), that carries out the same reaction
and, in fact, GlpX has been shown to be functional only when
overexpressed [64]. Since there seems to be no Fbp homologue in
F. tularensis, it is possible that GlpX is the sole enzyme responsible
for the conversion to fructose-6-phosphate in the species. The
extreme attenuation of the SCHU S4 mutant of GlpX, which
showed an LD50 of .10
7 CFU (Table 3), suggests that the
gluconeogenesis is critical for the full virulence of F. tularensis in vivo.
Our screening of transposon mutants identified several
additional attenuated strains. Based on these findings, deletion
mutants were generated and their virulence assessed. One of these
targets was c-glutamyl aminotranspeptidase (Ggt). It has a major
role in glutathione metabolism and is responsible for the first step
in the degradation pathway of glutathione, and transfers a c-
glutamyl moiety from glutathione to amino acids or uses it as a
source for cysteine. It can also contribute to the synthesis of
glutathione through the transfer of c-glutamyl peptides. A
transposon mutant was also identified by Qin et al as attenuated
for intracellular growth in a hepatocyte cell line and in
macrophages [42] and recently by Alkhuder et al. which showed
that F. tularensis LVS, in fact, utilized glutathione and gamma-
glutamyl-cysteine dipeptide as cysteine sources to ensure intracel-
lular growth [65]. We observed that the SCHU S4 mutant had an
LD50 of $10
5 CFU (Table 3). Thus, it is likely that also F. tularensis
SCHU S4 utilizes glutathione during its intracellular growth. Since
glutathione is abundant in the cytosol, it is a rational mechanism to
ensure an intracellular supply of c-glutamyl moieties and cysteine.
Also in Helicobacter pylori, a crucial role of Ggt has been identified
since a mutant was attenuated in both piglets and mice [66].
The RimK protein of Escherichia coli has been isolated and
characterized as a protein that adds glutamic acid residues to the
carboxyl terminus of ribosomal protein S6 of the organism [67].
The protein family including E. coli RimK encompasses a number
of proteins with ATP-dependent carboxylate-amine ligase activity,
where acylphosphate intermediates are involved in the catalytic
mechanism [68]. Moreover, it was demonstrated that a rimK
mutant in the extreme thermophile Thermus thermophilus demon-
strated a lysine auxotrophic phenotype [69] but this could
represent an adaptation to extreme living conditions, and may
have no relevance for human pathogens. Since it could be
predicted that RimK may contribute to ribosomal functions and
many times ribosomal dysfunctions lead to attenuation, we
included it in the study but no attenuation was observed (Table 3).
The LPS of F. tularensis constitutes a unique molecule
characterized by minimal endotoxicity [70]. The F. tularensis core
oligosaccharide chain from LPS is not well characterized but the
bacterium possesses a kdtA gene which in other bacteria is known
to encode a 3-deoxy-D-manno-2-octulosonic acid (Kdo) transfer-
ase [71]. The enzyme adds Kdo residues to the lipid A portion of
the LPS. A kdtA mutant of Moraxella catharralis demonstrated
enhanced clearance in lungs and nasopharynx in a mouse aerosol
model [72]. Similarly, we observed that the SCHU S4 DkdtA
deletion mutant showed marked attenuation (Table 3), but the
immunized mice did not show any extended time to death when
they 5 to 6 weeks later were challenged by ID or aerosol
administration of approximately 10 CFU of SCHU S4. The same
results were obtained with a SCHU S4 DwbtI mutant, a gene of
the lipopolysaccharide O-antigen synthesis. Three previous studies
have studied the properties of wbt mutants with regard to
intracellular replication and virulence in a mouse model
[11,73,74]. In agreement with our results, wbtI mutant of SCHU
S4, wbtDEF mutants of SCHU S4, LVS and F. novicida were
attenuated after intradermal challenge of mice. However, none of
them afforded protection against a homologous challenge [11].
Thus, it appears as if lipopolysaccharide mutations in general and
irrespective of F. tularensis subspecies give rise to highly attenuated
bacteria with minimal immunogenicity.
The strategy used herein, to screen targeted mutants for marked
attenuation in a mouse model has several caveats that have to be
considered when interpreting the results. One is the extreme
virulence of strains of subspecies tularensis in the mouse model. All
evidence indicates that one CFU is sufficient to cause a lethal
disease [35]. Thus, the level of attenuation has to be marked
before a significant increase in the LD50 can be observed. This is
evidenced by our previous study of the KatG mutant of SCHU S4
that was found to be as virulent as the parent strain with regard to
the LD50 although it showed markedly decreased bacterial
numbers in liver and spleen [13]. Normally, for other F. tularensis
strains, a very good correlation is found between the peak number
of CFU and outcome of infection [75]. The high virulence of
SCHU S4 most likely means that peak numbers of CFU have to
be several log10 lower before attenuation is evidenced as an
increased LD50. Another concern is a lack of complementation.
We have analyzed LVS mutants with in-frame deletions in each of
the four igl genes and our recently published data showed that
there were no significant effects of the expression of the three other
proteins in each of the four mutants and each of the phenotypes
could be complemented [19,46]. Thus, the in-frame deletions did
not confer polar effects on downstream genes and, therefore, the
effects of such deletions appear to be specific to the target genes,
supporting the notion that our findings in the present study
directly reveal if the target genes have an essential function.
Most studies on F. tularensis are carried out using the model
organisms F. novicida or LVS. As we demonstrated previously for
KatG, and in the present study for ChiA and TolC, the role of many
proteins are distinct in the model organisms compared to the highly
virulent subspecies holarctica or tularensis strains. Therefore, the data
from studies on F. novicida or LVS cannot simplybe extrapolated and
assumed to be relevant for highly virulent strains.
There are some general caveats regarding the use of an in vivo
screening model as a tool to search for virulence factors. If a specific
mutation has no effect on virulence, the finding does not necessarily
mean that the disrupted target plays no role in virulence since an
alternative pathway can compensate for the defect. Moreover,
virulence gene expression may depend on specific signaling, and,
thus, attenuation might be the effect of repression of virulence
factors. Another caveat is that a specific defect might play an
important role at one stage of infection but not at another, which is
not revealed by the screening method, e.g., the inactivated target can
play a role by a route of inoculation not employed. Since analysis of
virulencefactorsinwholeorganismsremains complex becauseof the
aforementioned caveats, ourresults haveto be interpreted with some
caution,butnonetheless,thepresenteddatawillbeimportantforour
understanding of virulence mechanisms utilized by this highly
virulent intracellular bacterium.
Materials and Methods
Bacterial strains
The F. tularensis strain SCHU S4 (subspecies tularensis) was
obtained from the Francisella Strain Collection (FSC) of the
Swedish Defence Research Agency, Umea ˚. The descriptions of the
Virulence Genes of SCHU S4
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Tables 2 and 3.
All in vitro bacteriological work was carried out in a biosafety
level 3 facility certified by Swedish Work Environment Authority
and also certified to be Select Agent compliant by the Centers for
Disease Control and Prevention, USA. Bacteria were routinely
cultivated on GC II Agar Base supplemented with IsoVitalex at
37uCi n5 %C O 2 overnight.
Construction of mutant strains
The upstream and downstream regions flanking each target
gene were amplified by means of Phusion DNA polymerase
(Finnzyme) and primer pairs (Table 4) were designated so that one
primer for the upstream region and one primer for the
downstream region contained 59end sequences complementary
to each other to provide ‘‘sticky’’ sequences for the following
overlapping PCR. The flanking regions were 1,000–1,500 bp for
all constructs except the ones for rimK, chiA, and FTT1149 that
were between 500 and 600 bp. The final PCR product was cloned
to pGEM-Teasy vector (Promega), and introduced in E. coli
TOP10 strain (Invitrogen), then subsequently re-cloned to the
pDMK2 vector using NotI sites and propagated in the strain E. coli
S17-1lpir. pDMK2 (GenBank accession no. FJ824848) is a
derivative of pDMK [13] with additional restriction sites in the
former. The resulting pDMK2 plasmid containing the deletion
construct was conjugatively transferred from S17-1 to SCHU S4
as described previously [76]. Clones with the respective derivative
of pDMK2 integrated into the SCHU S4 chromosome by a single
homologous recombination event were selected on plates contain-
ing kanamycin and polymyxin B, and the legitimate integration
was verified by PCR. Clones with correct integrations were then
subjected to sucrose selection. This procedure selected for a second
cross-over event in which the integrated plasmid, encoding sacB,
was excised from the chromosome. Kanamycin-sensitive clones
were examined by PCR confirming the deletion of the genes and
the exact location verified by sequencing. The exact sizes of the
deletions are indicated in Table 3. All deletions were in-frame,
thereby not affecting transcription downstream.
Screening for transposon insertion mutants
The EZ-Tn5,oriV/KAN-2.Insertion Kit (Epicentre Biotech-
nologies, Madison, WI) was used to create random transposon
insertion mutations in F. tularensis SCHU S4. The transposome
reaction mixture was prepared by mixing either the EZ::TN ,kan-
2. transposon (Epicentre) orthe kan-Ft transposon with transposase
in accordance to the Epicentre protocol with the addition of an
incubation at 220uC for at least 48 h. Kan-Ft is derivative of Kan-2
containing an F. tularensis codon-optimized version of aphA expressed
under control of a modified F. tularensis groEL promoter. The plasmid
containing kan-Ft was kindly provided by Dr Tom Kawula [77].
Electrocompetent F. tularensis cells were prepared essentially as
described by Kawula et al. [34] and 1 ml of the transposome was
used for electroporation into F. tularensis at 3.0 kV, 25 mF, and
200 ohms in an 0.1 cm electroporation cuvette. Immediately after
electroporation, the cells were suspended in 0.4 ml Chamberlain
medium, incubated for 4 h at 37uC, and then plated on GC II Agar
Base supplemented with IsoVitalex containing 10 mg/ml of
kanamycin. After overnight incubation, individual kanamycin-
resistant colonies were identified. Chromosomal DNA was prepared
by use of the DNAEasy Blood & Tissue Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. Transposon
insertion sites in the bacterial chromosome were determined by
direct sequencing of genomic DNA using Kan-2 FP-1 (ACCTA-
CAACAAAGCTCTCATCAACC) and Kan-2 RP-1 (GCAATG-
TAACATCAGAGATTTTGAG) for the Kan-2 transposon or
FtKmFP (GGCATGCAAGCTTGCCAACGA) and FtKmRP
(TCGAGCCAATATGCGAGAACAC) for the KanFt transposon.
For sequencing, the BigDye Terminator Kit (Applied Biosystem,
FosterCity,CA)wasused.Twotofivemgo fch ro mo so ma lD NAan d
10 pmolprimerwereusedandthereactionswerecarriedat95uCfo r
1 min followed by 60 cycles of 10 s at 95uC, 5 s at 55uC, and 4 min
at 60uC. The transposon insertion site was determined by aligning
thesequencetotheF.tularensisSCHUstraingenomedatabase(www.
Francisella.org). All mutants included in the study were unambig-
uously identified by this analysis.
Infection of mice
Mouse challenge experiments were performed at the National
Research Council of Canada, Institute for Biological Sciences in a
federally-licensed small animal containment level 3 facility that is
also approved by the NIH for Select Agent research. Specific-
pathogen-free female BALB/c mice were purchased from Charles
River Laboratories (St. Constant, Que.). Mice were maintained and
used in accordance with the recommendations of the Canadian
CouncilonAnimalCareGuidetotheCareandUseofExperimental
Animals. For intradermal inoculations, stocks of the strains were
diluted in sterile saline. Actual concentrations of inocula were
determined by plating. Intradermal inocula (50 ml/mouse) were
injected into a fold of skin in the shaved mid-belly. All deletion
mutants were initially administered as an intradermal inoculum of
10
3 CFU. If this dose was sublethal, additional mice were challenged
with 10
5 and 10
7 CFU. If 10
3 CFU was lethal, the mutant was also
given a dose of 10 CFU. In all cases, there were five mice per group.
Mice that survived the highest intradermal challenge dose were
subsequently exposed to a ,20 CFU smallparticleaerosol of SCHU
S4 as previously described [78]. All other survivors of mutant
challenges were challenged intradermally with 10
3 CFU of SCHU
S4. Whenever feasible, mice were euthanized by CO2 asphyxiation
as soon as they displayed signs of severe infection. In our experience
such mice were at most 24 h from death, and time to death of these
animalswasestimated onthispremise.Thesignificanceofprolonged
time to death of mice was determined by using the Logrank test. A P
value,0.05 was considered significant.
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